ROX Medical has completed the enrollment of the first patient in its CONTROL-HTN trial, designed to demonstrate the safety and efficacy of the minimally invasive catheter procedure in treating resistant hypertension. The controlled, ...
Tags: ROX Medical, CONTROL-HTN trial, minimally invasive catheter procedure
Medtronic has begun its minimally invasive Symplicity renal denervation system's clinical trial in Japan to treat patients who are not responding to different types of anti-hypertensive medications and are at risk of stroke. The ...
Boston Scientific has entered into a definitive agreement to buy all the assets of Vessix Vascular for an upfront payment of $125m. Under the acquisition, Vessix Vascular will be integrated into Boston Scientific's peripheral ...
ReCor Medical has presented six-month follow-up data of eight patients treated via renal denervation with the company's Paradise system. The CE-marked Paradise system for renal denervation is based on ultrasound, not radiofrequency, ...
Tags: ReCor Medical, renal denervation, resistant hypertension patients
Kona Medical has raised additional $10m in equity and debt financing round to bring its total proceeds to $40m. The funding round, in addition to its prior investors Essex Woodlands, Domain Associates, Morgenthaler Ventures, Western ...
Tags: Kona Medical, Series C financing, ultrasound
St Joseph Hospital has enrolled first patient for SYMPLICITY HTN-3 trial, conducted by Medtronic, designed to assess investigational Symplicity renal denervation system. Minimally invasive, catheter-based renal denervation procedure is ...
Tags: renal denervation system, catheter-based renal denervation